Frontlight ResearchEarly access
Taking peoplePhase 3
Clinical Randomisation of an Anti-fibrinolytic in Symptomatic Mild Head Injury in Older Adults
Key facts
- Who runs it
- London School of Hygiene and Tropical Medicine
- Where
- United Kingdom2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- Phase
- Phase 3
- People taking part
- 5,000 people, planned
- Started
- 18 Apr 2021
- Expected to end
- 31 Jan 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Tranexamic Acid 500 MG
- Record updated
- 12 March 2026
Who can take part
- Age
- 50 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- 50 years or older (actual or estimated)
- History or evidence of head injury (e.g. laceration, bruise, swelling or pain in head or face)
- GCS ≥ 13
- Has one or more of the following:; has or had any impaired consciousness (loss of consciousness, amnesia, or confusion); nausea or vomiting
- Within 3 hours of injury (do not include if interval cannot be estimated e.g. patient unable to confirm time of fall or patient found on floor after an unwitnessed fall and home alone)
- Not living in a nursing home, mental health institution or prison
- Patient will be conveyed to or is admitted to a participating hospital
Who cannot take part
- TXA not clearly indicated (e.g. major bleeding) or contraindicated (e.g. suspected stroke)
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Tranexamic acid (TXA) reduces head injury deaths. The CRASH-4 trial aims to assess the effects of early intramuscular TXA on intracranial haemorrhage, disability, death, and dementia in older adults with symptomatic mild head injury
The 2 groups in the trial
- ActiveExisting treatment, for comparison
A single dose of Tranexamic acid 500mg given by intramuscular injection
Treatment: Tranexamic Acid 500 MG
- PlaceboPlacebo, for comparison
One Injection of the placebo which is 10 mL Sodium Chloride (0.9%)
Treatment: Tranexamic Acid 500 MG
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Intramuscular Tranexamic Acid for the Treatment of Symptomatic Mild Traumatic Brain Injury in Older Adults: a Randomised, Double-blind, Placebo-controlled Trial
- Record updated
- 12 March 2026